Cargando…
SIRT3 as a Regulator of Non-alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease (NAFLD) is a hepatic presentation of obesity and metabolic syndrome. NAFLD includes a large spectrum of hepatic pathologies that range from simple steatosis and non-alcoholic steatohepatitis (NASH), to liver cirrhosis without an all-encompassing approved therapeutic...
Autor principal: | Cho, Eun-Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Institute of Lifestyle Medicine, Yonsei University Wonju College of Medicine
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391020/ https://www.ncbi.nlm.nih.gov/pubmed/26064858 http://dx.doi.org/10.15280/jlm.2014.4.2.80 |
Ejemplares similares
-
Role of the AMPK/SIRT1 pathway in non-alcoholic fatty liver disease (Review)
por: Anggreini, Putri, et al.
Publicado: (2022) -
Transcriptional Regulation in Non-Alcoholic Fatty Liver Disease
por: Steensels, Sandra, et al.
Publicado: (2020) -
The effects of moderate alcohol consumption on non-alcoholic fatty liver disease
por: Oh, Hyunwoo, et al.
Publicado: (2023) -
Role of Microbiota-Derived Metabolites in Alcoholic and Non-Alcoholic Fatty Liver Diseases
por: Park, Ji-Won, et al.
Publicado: (2021) -
Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease
por: Valenzuela-Vallejo, Laura, et al.
Publicado: (2023)